BRISTOL-MEYERS SQUIBB COMPANY | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for BRISTOL-MEYERS SQUIBB COMPANY

Sort by

Viewing results 1‒25 of 836

InterviewBristol-Myers Squibb Co
Bristol Myers Squibb drafts contingency plans for US restrictions on Chinese pharma
...Bristol Myers Squibb is working on contingency plans to “protect the continuity of supply” of medicine in preparation for draft US legislation seeking to restrict Chinese pharmaceutical companies over national...
April 25, 2024
News updates from February 14: UK inflation holds steady, Uber debuts $7bn share buyback
Bristol Myers Squibb raises $13bn in bond deal to fund M&A
...Bristol Myers Squibb raised $13bn in a large bond deal on Wednesday that will help fund two acquisitions....
February 14, 2024
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
News updates from October 26: US GDP rises 4.9%, Ford strikes deal with auto union
Bristol Myers Squibb delays new-drug sales target by one year
...Bristol Myers Squibb has pushed out by one year its sales target for a new crop of drugs, guiding that the pharmaceutical company’s goal of at least $10bn would now not be achieved until 2026....
October 26, 2023
Live news: Scottish power-sharing deal collapses over scrapped climate targets
What to watch in North America today
...Other earnings: Merck, Caterpillar, Honeywell, Bristol Myers Squibb, Altria, Northrop Grumman, Royal Caribbean Cruises, Southwest Airlines, American Airlines, Harley-Davidson and Hertz are reporting before...
April 25, 2024
LexPharmaceuticals sector
Big Pharma still needs trial success to overcome looming patent panic Premium content
...Still, that has not stopped investors from fretting about pipeline replacement at companies such as Bristol Myers Squibb (BMS), Sanofi and Roche....
February 6, 2024
News updates from November 20: OpenAI staff threaten to quit unless directors resign, Argentine stocks rally over election of Milei
Risers and fallers in the US
...Pharmaceutical company Bristol Myers Squibb fell 3.5 per cent after the federal US drug regulator delayed its decision to expand the use of a cancer therapy and as rival Bayer stopped a late-stage study...
November 20, 2023
FT Live
Global Pharma and Biotech Summit
Driving life sciences innovation in a disrupted world
Tuesday, 5 NovemberIn-Person & Online Conference
FirstFT
FirstFT: BHP proposes all-stock takeover of Anglo American
...Earnings are also expected from Merck, Caterpillar, Honeywell, Bristol Myers Squibb, Altria, Northrop Grumman, Royal Caribbean Cruises, Southwest Airlines, American Airlines, Harley-Davidson and Hertz before...
April 25, 2024
LexDrug prices
Innovation is the only defence against drug price crackdown Premium content
...The impact could be significant for companies such as Bristol Myers Squibb. Its blood thinner Eliquis is expected to account for more than a quarter of sales in 2026, according to Visible Alpha....
February 1, 2024
LexEli Lilly & Co
Eli Lilly’s heavyweight status looks set to last Premium content
...A price to forward earnings multiple of over 50 values the stock more like a tech company than a pharma group. Bristol Myers Squibb trades on just seven times earnings while Pfizer is on 20 times....
January 16, 2024
Corporate bonds
Investors shun riskiest US corporate bonds on default fears
...High-grade pharma group Bristol Myers Squibb sold $13bn of debt on Wednesday....
February 19, 2024
Deepmind Technologies Ltd
DeepMind spin-off aims to halve drug discovery times following Big Pharma deals
...Oxford-based Exscientia is working with Sanofi and Bristol Myers Squibb, among others, and Insitro has a deal with Bristol Myers, while Owkin is also collaborating with Sanofi....
January 10, 2024
Insider trading
UK billionaire Joe Lewis pleads guilty in US insider trading case
...Mirati, which was purchased by Bristol Myers Squibb in a deal announced last year, did not immediately respond to a request for comment....
January 24, 2024
The Week Ahead
Opening arguments begin in Trump trial
...Key economic and company reports Here is a more complete list of what to expect in terms of company reports and economic data this week....
April 21, 2024
IPOs
Strong gains by newly listed stocks raise hopes of IPO market revival
...Myers Squibb would buy the biotech company....
January 10, 2024
News updates from August 25: Powell addresses Jackson Hole, Instacart files for IPO
AstraZeneca joins pharma groups in suing US over drug price reforms
...Other drugmakers including Merck, Bristol Myers Squibb, and Johnson & Johnson, as well as the US pharmaceutical lobby group, have already filed lawsuits against the reforms....
August 25, 2023
FT Live
The Global Boardroom: 8th Edition
FT journalists in conversation with leaders in business and government
Wednesday, 4 DecemberDigital Conference
On Wall StreetJames Fontanella-Khan
Banks hope for M&A revival despite the geopolitics
...In the pharmaceutical industry, big companies including AstraZeneca, AbbVie and Bristol Myers Squibb have announced about $25bn worth of biotech-related deals....
January 13, 2024
FirstFT
FirstFT: Meta rewards investors with first dividend and $50bn buyback
...Pharmaceutical groups Bristol Myers Squibb, Regeneron and AbbVie are also expected to release earnings....
February 2, 2024
News updates from July 19: Goldman Sachs profit tumbles as slowdown hits trading, UK inflation falls more than expected in June
Johnson & Johnson sues US government over drug price controls
...The company joins Merck, Bristol Myers Squibb and the lobby group Pharmaceutical Research and Manufacturers of America in challenging the new law....
July 18, 2023
Live news updates from July 18: BBC hires Deloitte to review procedures, Morgan Stanley profits fall
Johnson & Johnson sues US government over drug price controls
...Johnson & Johnson joins the Merck, Bristol Myers Squibb and pharmaceutical lobby Pharmaceutical Research and Manufacturers of America in challenging the new law....
July 18, 2023
AstraZeneca PLC
AstraZeneca sues US government over drug price reforms
...Other drugmakers including Merck, Bristol Myers Squibb, and Johnson & Johnson, as well as the US pharmaceutical lobby group, have already filed lawsuits against the reforms....
August 25, 2023
Drug prices
Novartis boss warns US drug pricing reform poses risk to public health
...Bristol Myers Squibb told the FT last year it expected to cancel some drug programmes, with cancer medicines most vulnerable....
July 25, 2023
The Week Ahead
Groundhog Day rings true for US politics
...Key economic and company reports Here is a more complete list of what to expect in terms of company reports and economic data this week....
January 28, 2024
LexDrug prices
US drug prices: Medicare curbs may be more show than tell Premium content
...They include Eliquis, a blood thinner produced by Bristol Myers Squibb (BMS) and its partner Pfizer, the diabetes treatment Jardiance sold by Boehringer Ingelheim and Eli Lilly, and Xarelto, another blood...
August 29, 2023
Drug prices
Bristol Myers Squibb warns US price reforms will dent drug development
...Bristol Myers Squibb says it expects to cancel some drug development programmes due to US government drug pricing rules that are due to be phased in from next year....
November 20, 2022
US politics & policy
US targets 10 drugs for pricing negotiations in crackdown on costs
...Myers Squibb; and a Novartis drug to treat heart failure called Entresto....
August 29, 2023

Previous pagePage 1 of 34Next page